Nevaeh Celebrates Two Years with Her New Heart
Two-year-old Nevaeh celebrates two years with her new heart at Hassenfeld Children’s Hospital at NYU Langone.
New Academic & Medical Director of Liver Cancer Program
Perlmutter Cancer Center names Augusto Villanueva Rodriguez, MD, PhD, as the new academic and medical director of its Liver Cancer Program.
New Adult Primary Care Practice in Chelsea
The newly opened NYU Langone Medical Associates—Chelsea, West 25th Street is a comprehensive care center for adults that offers sexual healthcare services.
New Advances in Cardiac & Vascular Research
Investigators at NYU Langone Health have made fundamental strides in cardiovascular research over the last year.
New AI Tool Makes Speedy Gene Editing Possible
NYU Langone’s artificial intelligence program quickly designs customizable proteins to treat diseases by turning genes on and off.
New Alzheimer’s Drug Is First of Its Kind to Be FDA Approved
NYU Langone neurologist Dr. Joel Salinas discusses the FDA approval of Aduhelm (aducanumab) to treat early Alzheimer’s disease.
New Alzheimer’s Research Targets Amyloid Beta Proteins
NYU Langone Alzheimer’s and dementia researchers present latest findings at 2016 Alzheimer’s Association International Conference.
New Ambulatory Care Center Opens in Midtown Manhattan
NYU Langone Ambulatory Care Center East 41st Street, opening April 9, 2018, is one of NYU Langone’s largest ambulatory facilities.
New Anti-Aging Properties Found in Old Diabetes Drugs
NYU Langone researchers find that a type of medication used to increase insulin sensitivity can prevent or delay many age-related pathologies.
New Antibodies Show Potential Against Neurological Diseases
NYU Langone study finds experimental antibodies target a structural feature shared by proteins linked to several neurological conditions.